Alteration of the hair matrix by cosmetic products presents a challenge for forensic hair analysis. Oxidative treatments lead to analyte depletion and false-negative results. Currently, the degradation product of eumelanin, 1H-pyrrole-2,3,5-tricarboxylic acid (PTCA) is being investigated as a marker for oxidative hair treatment; however, it requires the definition of the cut-off value. Recently, it has been shown that 1H-pyrrole-2,3,4,5-tetracarboxylic acid (PTeCA) also increased significantly after in vitro oxidative hair treatments. Here, our previously published LC-MS/MS method for hair PTCA has been fully validated for the simultaneous quantification of PTeCA (range 0.01–2.5 ng/mg; lower limit of quantification [LLOQ] 0.003 ng/mg). The method was applied to 3378 self-reported treated (T) and untreated (UT) hair samples (3–6 cm proximal). In addition, the in vitro formation of PTeCA was assessed in 225 UT hair samples by different professional cosmetic treatments with and without oxidative agents. In the UT group (N = 1144), PTCA was determined in about 40% of the samples with a median PTCA of 0.04 ng/mg (range 0.01–14.9 ng/mg) and PTeCA was >LLOQ in < 2% of the samples (N = 53). In the T group (N = 425), PTCA was determined in 84% of the samples with a median of 0.75 ng/mg (range 0.01–58.1 ng/mg); while the median PTeCA was 0.40 ng/mg (N = 243; range 0.02–31.2 ng/mg). Moreover, the in vitro cosmetic treatment confirmed the PTeCA formation only in oxidative conditions. Finally, a PTCA cut-off value was proposed using PTeCA as the gold standard. Our data suggest that PTeCA could be a reliable marker for detecting oxidative cosmetic treatments in the hair matrix.
In Vivo and In~Vitro Evaluation of PTeCA (1H-Pyrrole-2,3,4,5-Tetracarboxylic Acid) in Hair Matrix as a Marker for Oxidative Cosmetic Treatment / S. Casati, A.R.. - In: DRUG TESTING AND ANALYSIS. - ISSN 1942-7603. - 18:6(2026 Jun), pp. 739-749. [10.1002/dta.70068]
In Vivo and In~Vitro Evaluation of PTeCA (1H-Pyrrole-2,3,4,5-Tetracarboxylic Acid) in Hair Matrix as a Marker for Oxidative Cosmetic Treatment
S. Casati
Primo
;A. RavelliSecondo
;R. Bergamaschi;S. Vanerio;G. Roda;P. Rota;M. OrioliPenultimo
;A. BattistiniUltimo
2026
Abstract
Alteration of the hair matrix by cosmetic products presents a challenge for forensic hair analysis. Oxidative treatments lead to analyte depletion and false-negative results. Currently, the degradation product of eumelanin, 1H-pyrrole-2,3,5-tricarboxylic acid (PTCA) is being investigated as a marker for oxidative hair treatment; however, it requires the definition of the cut-off value. Recently, it has been shown that 1H-pyrrole-2,3,4,5-tetracarboxylic acid (PTeCA) also increased significantly after in vitro oxidative hair treatments. Here, our previously published LC-MS/MS method for hair PTCA has been fully validated for the simultaneous quantification of PTeCA (range 0.01–2.5 ng/mg; lower limit of quantification [LLOQ] 0.003 ng/mg). The method was applied to 3378 self-reported treated (T) and untreated (UT) hair samples (3–6 cm proximal). In addition, the in vitro formation of PTeCA was assessed in 225 UT hair samples by different professional cosmetic treatments with and without oxidative agents. In the UT group (N = 1144), PTCA was determined in about 40% of the samples with a median PTCA of 0.04 ng/mg (range 0.01–14.9 ng/mg) and PTeCA was >LLOQ in < 2% of the samples (N = 53). In the T group (N = 425), PTCA was determined in 84% of the samples with a median of 0.75 ng/mg (range 0.01–58.1 ng/mg); while the median PTeCA was 0.40 ng/mg (N = 243; range 0.02–31.2 ng/mg). Moreover, the in vitro cosmetic treatment confirmed the PTeCA formation only in oxidative conditions. Finally, a PTCA cut-off value was proposed using PTeCA as the gold standard. Our data suggest that PTeCA could be a reliable marker for detecting oxidative cosmetic treatments in the hair matrix.| File | Dimensione | Formato | |
|---|---|---|---|
|
Drug Testing and Analysis - 2026 - Casati - In Vivo and In Vitro Evaluation of PTeCA 1H‐Pyrrole‐2 3 4 5‐Tetracarboxylic.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
1.94 MB
Formato
Adobe PDF
|
1.94 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




